Inventors:
Scot Ebbinghaus - Lansdale PA, US
International Classification:
A61K 31/675, A61P 35/00, C07F 9/32
Abstract:
The invention provides a method for treating NSCLC, especially in cases of KRAS mutation, involving the administration of deforolimus.